which bpc 157 does huberman recommend Peptides and BPC-157 for Pain: What's the deal? Origins & Effects of BPC-157

Schrempf, W., M

Specification BPC-157 TB-500 (Thymosin Beta-4) Cartalax (AED) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Ala-Glu-Asp Molecular Formula C62H98N16O22 C212H350N56O78S C12H19N3O8 Molecular Weight 1419.5 g/mol 4963.4 g/mol 333.29 g/mol CAS Number 137525-51-0 77591-33-4 205640-90-0 PubChem CID 9941957 16132341 87815447 Synonyms Bepecin, Bpc 15, Body protection compound 15, Pentadecapeptide Thymosin Beta 4, Thymosin 4, TB500, Timbetasin T-31, AED, Alanyl-glutamyl-aspartic acid

Although epidemiologic studies have shown an association between vascular disease and hyperhomocysteinemia, large randomized controlled trials have shown that lowering homocysteine levels in these patients does not reduce the number of myocardial infarctions or strokes, or improve mortality rates

BPC-157 upregulates VEGFR2 and modulates the nitric oxide and FAK-paxillin pathways

Usage under expert guidance is crucial